Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSolGold Regulatory News (SOLG)

  • This share is currently suspended. It was suspended at a price of 27.95
  • There is currently no data for SOLG

Form 8.3 SOLGOLD PLC

3 Mar 2026 13:15

RNS Number : 1693V
Barclays PLC
03 March 2026
Ā 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Ā 

Barclays PLC.

(b)

Owner or controller of interest and short

Ā 

Ā 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

SOLGOLD PLC

Ā 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Ā 

Ā 

offeror/offeree, state this and specify identity of

Ā 

offeror/offeree:

(e)

Date position held/dealing undertaken:

02 Mar 2026

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Ā 

Ā 

Ā 

disclosures in respect of any other party to the offer?

Ā 

Ā 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Ā 

Ā 

to which the disclosure relates following the dealing(if any)

Ā 

Class of relevant security:

1p ordinary

Ā 

Interests

Short Positions

Ā 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Ā 

Ā 

Ā 

Ā 

Ā 

and/or controlled:

Ā 

Ā 

67,296,215

2.23%

1,633,859

0.05%

(2)

Cash-settled derivatives:

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

1,633,310

0.05%

67,268,781

2.23%

(3)

Stock-settled derivatives (including options)

Ā 

Ā 

Ā 

Ā 

Ā 

and agreements to purchase/sell:

Ā 

Ā 

0

0.00%

0

0.00%

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

TOTAL:

Ā 

Ā 

68,929,525

2.29%

68,902,640

2.29%

(b)

Rights to subscribe for new securities (including directors and other executive

Ā 

Ā 

options)

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant security in relation to

Ā 

Ā 

Ā 

Ā 

which subscription right exists

Ā 

Ā 

Ā 

Ā 

Details, including nature of the rights

Ā 

Ā 

Ā 

Ā 

concerned and relevant percentages:

Ā 

Ā 

Ā 

Ā 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Ā 

securities

Ā 

1p ordinary

Purchase

1,075,352

0.2793 GBP

1p ordinary

Purchase

749,079

0.2795 GBP

1p ordinary

Purchase

325,014

0.2797 GBP

1p ordinary

Purchase

75,365

0.2800 GBP

1p ordinary

Purchase

1,995

0.2794 GBP

1p ordinary

Purchase

1,624

0.2790 GBP

1p ordinary

Purchase

1,212

0.2789 GBP

1p ordinary

Sale

1,107,163

0.2795 GBP

1p ordinary

Sale

1,023,679

0.2800 GBP

1p ordinary

Sale

950,937

0.2797 GBP

1p ordinary

Sale

379,047

0.2799 GBP

1p ordinary

Sale

156,229

0.2796 GBP

1p ordinary

Sale

14,751

0.2798 GBP

1p ordinary

Sale

5,318

0.2793 GBP

1p ordinary

Sale

3,248

0.2790 GBP

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(b)

Cash-settled derivative transactions

Ā 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Ā 

reference

unit

security

Ā 

Ā 

securities

Ā 

1p ordinary

SWAP

Decreasing Short

1,351

0.2793 GBP

1p ordinary

SWAP

Decreasing Short

833,530

0.2795 GBP

1p ordinary

SWAP

Decreasing Short

14,751

0.2797 GBP

1p ordinary

SWAP

Decreasing Short

520,967

0.2799 GBP

1p ordinary

SWAP

Decreasing Short

108,468

0.2800 GBP

1p ordinary

SWAP

Increasing Short

12,848

0.2790 GBP

1p ordinary

SWAP

Increasing Short

16,800

0.2795 GBP

1p ordinary

SWAP

Increasing Short

66,672

0.2800 GBP

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(c)

Stock-settled derivative transactions (including options)

Ā 

(i)

Writing, selling, purchasing or varying

Ā 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Ā 

date

money

relevant

Ā 

selling,

securities

per unit

Ā 

Ā 

paid/

security

Ā 

varying etc

to which

Ā 

Ā 

Ā 

received

Ā 

Ā 

Ā 

option

Ā 

Ā 

Ā 

per unit

Ā 

Ā 

Ā 

relates

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(ii)

Exercise

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Ā 

Ā 

securities

unit

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(d)

Other dealings (including subscribing for new securities)

Ā 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Ā 

Ā 

applicable)

Ā 

Ā 

Ā 

Ā 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Ā 

Details of any indemnity or option arrangement, or any agreement or understanding,

Ā 

Ā 

formal or informal, relating to relevant securities which may be an inducement to deal

Ā 

Ā 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Ā 

to the offer or any person acting in concert with a party to the offer:

Ā 

Ā 

Ā 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Ā 

Details of any agreement, arrangement or understanding, formal or informal, between

Ā 

Ā 

the person making the disclosure and any other person relating to:

Ā 

Ā 

(i) the voting rights of any relevant securities under any option; or

Ā 

Ā 

Ā 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Ā 

Ā 

any derivative is referenced:

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

NONE

(c)

Attachments

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

03 Mar 2026

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
RETAKNBDNBKDQNK
Date   Source Headline
17th Sep 20257:00 amRNSDrilling Reports at Tandayama
1st Sep 20257:00 amRNSTransition of Corporate Domicile
19th Aug 20254:44 pmRNS-RAnnounces Canaccord Genuity Engagement
15th Aug 20257:00 amRNSExceptional Near-Surface Intercepts at Tandayama
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20257:00 amRNSMultiple High-Grade Intervals at Tandayama-América
21st Jul 20257:00 amRNS$33.3M Received from Franco-Nevada & OR Royalties
17th Jul 20257:00 amRNSProject Execution Plan
10th Jul 20257:00 amRNSUS$33.3M Second Advance Under Stream Financing
4th Jun 20253:53 pmRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSVoluntary Delisting from Toronto Stock Exchange
16th May 20257:00 amRNSQ3 Financial Report and Quarterly MD&A
12th May 20257:03 amRNSEnvironmental Licence Granted for Porvenir Project
1st May 20257:00 amRNSCascabel Amended Investment Protection Agreement
15th Apr 20256:14 pmRNSDirector/PDMR Shareholding
15th Apr 20253:10 pmRNSSolGold Early Production Open Pit Strategy
27th Mar 20252:37 pmRNSHolding(s) in Company
26th Mar 20255:56 pmRNSHolding(s) in Company
24th Mar 20257:03 amRNSJiangxi Copper Investment Conditions Satisfied
14th Mar 20257:00 amRNSAppointment of Senior Independent Director
12th Mar 20258:01 amRNSFurther Investment from Jiangxi Copper
4th Mar 20258:00 amRNSNew CEO and Chair, and Re-Setting Company Strategy
21st Feb 202510:15 amRNSStatement re Litigation with Ex-CEO
14th Feb 20257:00 amRNSQ2 Financial Report and Quarterly MD&A
14th Jan 20256:11 pmRNSBlock Listing Six Monthly Return
5th Dec 20244:58 pmRNSResult of AGM
28th Nov 20246:00 pmRNSShareholder Update on Voting Process
18th Nov 20247:00 amRNSKey Milestones and Outlook for the Year Ahead
15th Nov 20247:13 amRNSQ1 Financial Report and Quarterly MD&A
7th Nov 20242:39 pmRNSNotice of AGM
4th Nov 20247:00 amRNSGeotechnical Investigations Commence at Cascabel
28th Oct 20247:00 amRNSCascabel Project Update
16th Oct 20247:00 amRNSCompany Update
27th Sep 20247:00 amRNSRelease of FY24 Annual Report and Accounts
16th Sep 20247:00 amRNSCompany Update
14th Aug 20244:57 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSCascabel Project Update
12th Aug 20243:30 pmRNSDirector/PDMR Shareholding
1st Aug 20246:20 pmRNSDirector/PDMR Shareholding
26th Jul 202412:08 pmRNSBlock Listing Six Monthly Return
18th Jul 20245:25 pmRNSPDMR Dealing
15th Jul 20247:00 amRNSUS$750M Financing Package for the Cascabel Project
25th Jun 20244:15 pmRNSFinancing Update
6th Jun 20247:00 amRNSExploitation Contract for Cascabel Project
16th May 20247:00 amRNSThird-Quarter Financial Report and Quarterly MD&A
14th May 20247:00 amRNSKey Financial Developments
15th Apr 20245:17 pmRNSDirector/PDMR Shareholding
12th Apr 20244:00 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSBlanca-Nieves Project Update
12th Mar 20247:00 amRNSPre-Feasibility Study Technical Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.